file_download Download slide in HQ

Index for
slide deck

Title

Shorter Duration of Psychosis Led to Improved Outcomes in Patients with First-Episode Schizophrenia
Shorter Duration of Psychosis Led to Improved Outcomes in Patients with First-Episode Schizophrenia

DUI=duration of untreated illness; DUP=duration of untreated psychosis.

References
  1. Owens DC et al. Br J Psychiatry. 2010;196(4):296-301.
  2. Primavera D et al. Ann Gen Psychiatry. 2012;11(1):21
file_download Download slide in HQ
The Value of a Support System
The Value of a Support System

CATIE=Clinical Antipsychotic Trials of Intervention Effectiveness.

References
  1. Glick ID et al. J Clin Psychopharmacol. 2011;31(1):82-85.
file_download Download slide in HQ
Family-Supervised Treatment Led to Significant Improvement in Symptoms and Functioning
Family-Supervised Treatment Led to Significant Improvement in Symptoms and Functioning

Intervention involved supervised treatment in outpatients for schizophrenia (STOPS). GAF=global assessment of functioning; PANSS™=Positive and Negative Syndrome Scale, a trademark of Multi-Health Systems, Inc.

References
  1. Farooq S et al. Br J Psychiatry. 2011;199(6):467-472.
file_download Download slide in HQ
Involving Patients in Their Own Care Increases Knowledge About Their Disease
Involving Patients in Their Own Care Increases Knowledge About Their Disease

*  Knowledge was assessed with a 7-item questionnaire about the patient’s disease and its treatment.

COMRADE=Combined Outcome Measure for Risk Communication and Treatment Decision Making Effectiveness.

References
  1. Hamann J et al. Acta Psychiatr Scand. 2006;114(4):265-273.
file_download Download slide in HQ

Related content

image Image
Trajectories of neurodegeneration in body- and brain-first subtypes of Lewy body disease

In brain-first patients (bottom panel), the dopamine system starts to degenerate early

23.01.2025 Parkinson’s Disease
image Image Characteristics of proposed body-first and brain-first subtypes of PD. Arrows indicate the direction of spread of α-synuclein pathology. In body-first Parkinson disease (left), the first α-synuclein aggregation occurs in the gut and propagates through the sympathetic nervous system to the sympathetic trunk and heart, and via the vagus nerve to the brainstem. Autonomic dysfunction and REM sleep behaviour disorder (RBD) are prodromal features. In brain-first PD (right), the initial α-synuclein pathology enters via the olfactory bulb (OB) and spreads to the amygdala and nigrostriatal dopamine system. The pathology then descends through the brainstem and RBD and dysautonomia generally develop after the onset of parkinsonism. During the later disease stages, nearly all patients have widespread pathology in these systems and their symptomatology therefore converges.
Body-first vs brain-first Lewy Body Disease

Characteristics of proposed body-first and brain-first subtypes of Parkinson’s disease

23.01.2025 Parkinson’s Disease
image Image
The Trajectory of Brain-first and Body-first PD

The body-first and brain-first model suggests that the clinical subtype with mild or no “bodily symptoms” before diagnosis reflects a brain-first origin of the disease

23.01.2025 Parkinson’s Disease